中晚期原发性肝癌超选择肝动脉插管化疗和栓塞的临床研究  

Clincal research on treatment of moderate and advanced stages of primary hepatocelular carcinoma with superselective transcatheter arterial chemoembolization

作　　者：辜斌[1] 况圣佳[1] 左慧英[1] 迟海波[1] 曾庆娥[1] 赵异才[1] 

机构地区：[1]江西医学院第一附属医院介入室,南昌330006

出　　处：《肿瘤研究与临床》2006年第2期111-112,共2页Cancer Research and Clinic

摘　　要：目的研究中晚期原发性肝癌经肝动脉超选择性插管化疗与栓塞的疗效。方法对1997年以来的中晚期原发性肝癌患者369例,经肝动脉超选择性插管化疗与栓塞治疗后,评价和随访疗效。结果患者的临床症状明显缓解,肿块缩小,AFP值下降;患者治疗后1￣5年生存率明显提高,生活质量得到改善。结论经肝动脉超选择性插管化疗与栓塞是中晚期原发性肝癌的有效治疗手段。Objective To evaluate the clinical efficacy of superselective transcatheter arterial chemoembolization （STACE） in treatment of moderate and advanced stages of primary hepatocellular carcinoma. Methods 369 patients with moderate and advanced stages of HCC were undergoing STACE. The efficacy of treatment was follow-up and evaluated. Results The clinical symptom of patients was significantly relieved; The AFP level in serum and tumor size were significantly decreased. After 1 to 5 year follow up, the survival rate and quality of life were significantly improved. Conclusion In the treatment of moderate and advanced stages of primary hepatocellular carcinoma, superselective transcatheter arterial chemoembolization is an efficient and safe method for raising the therapeutic effect.

关 键 词：肝肿瘤 肝动脉插管栓塞 

分 类 号：R735.7[医药卫生—肿瘤]